SCHEMBL20018464

SCHEMBL20018464

CCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 8/20 0.44
▸ NOD1 Q9Y239 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ P2RY12 Q9H244 2/20 0.42
▸ CASP2 P42575 1/20 0.42
▸ FAAH O00519 1/20 0.41
▸ SIRT2 Q8IXJ6 2/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16010862 0.90 FOLH1 (0.41) KMT2AEPHX2TDP1
SCHEMBL18396048 0.90 FOLH1 (0.41) KMT2AEPHX2TDP1
SCHEMBL30031700 0.90 FOLH1 (0.41) KMT2AEPHX2TDP1
SCHEMBL18396046 0.90 FOLH1 (0.41) KMT2AEPHX2TDP1
SCHEMBL16010863 0.90 FOLH1 (0.41) KMT2AEPHX2TDP1
SCHEMBL29551974 0.89 NOD1 (0.48) GLP1RNOD1KMT2AL3MBTL1
SCHEMBL25963705 0.89 TDP1 (0.43) KMT2AL3MBTL1EPHX2TDP1
SCHEMBL18770775 0.89 KMT2A (0.43) GLP1RNOD1KMT2ATDP1
SCHEMBL22228935 0.89 KMT2A (0.43) GLP1RNOD1KMT2ATDP1
SCHEMBL22247624 0.89 KMT2A (0.43) GLP1RNOD1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3545978-A1 TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS Molecular Insight Pharmaceuticals, Inc. (US) 2019-10-02 — — EP disclosed
EP-3300746-B1 TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS MOLECULAR INSIGHT PHARM INC (US) 2019-05-15 — — EP disclosed
EP-3300746-A1 TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS Molecular Insight Pharmaceuticals, Inc. (US) 2018-04-04 — — EP disclosed
Send feedback